All Articles

Biomarker advancements are revolutionizing cancer care by enabling personalized treatments, improving patient outcomes, and addressing challenges in testing, access, and care coordination—offering valuable insights into the future of oncology.

Although biomarker-driven targeted therapies for gastric cancer have advanced significantly, many eligible patients are not receiving these treatments, highlighting the urgent need to overcome barriers such as insufficient biomarker testing and socioeconomic disparities.

In this heartfelt reflection, a nurse navigator shares how personalized education and the teach-back method eased a patient’s hesitation with a colonoscopy, emphasizing the critical value of meeting individuals at their level of understanding.

This groundbreaking study reveals how AI-enabled interventions have the potential to revolutionize patient navigation by reducing burnout, increasing capacity, and creating sustainable healthcare solutions tailored to individual patient needs.

The findings on metastatic breast cancer patient navigation don't just highlight training gaps—they point to an opportunity that, if seized, could make all the difference for those who need support most.

A CATCH is a navigation success story where a navigation tactic improved a patient’s situation. This month, we profile the experience of a navigator who coordinated staging scans for her patient to ensure they were completed the day before the patient had her oncology consultation. The May 2025 CATCH is awarded to Kimary Kulig, PhD, MPH, at My Biomarker Navigator.

Navigation goes beyond just treating the cancer itself and includes addressing the patient’s physical, emotional, and social needs via a diverse team of healthcare professionals who collaborate to develop the best treatment plan for each patient.

Since the signing of the 1971 National Cancer Act, the United States has made remarkable progress in understanding and treating cancer, resulting in declining mortality rates—although these benefits haven’t reached poor and uninsured populations equally.

Patient navigation—provided locally in rural settings, in urban settings with programs designed to support rural residents, or a combination of in-person and virtual support through innovative programs—can enhance care delivery and mitigate the rural oncologist shortage while providing quality and culturally tailored cancer care.

Bispecific antibodies represent a promising advancement in cancer immunotherapy that simultaneously targets 2 different antigens to enhance immune response against cancer cells; however, their adoption shows significant disparities between well-equipped urban medical centers and underserved rural healthcare settings.